Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study

Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study

Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study 200 259 Curaleaf Australia
UK Medical Cannabis Registry: A Cohort Study of Patients Prescribed Cannabis-based Oils and Dried Flower for Generalised Anxiety Disorder
Assessment of Clinical Outcomes in Patients With Inflammatory Arthritis: Analysis From the UK Medical Cannabis Registry

©2026 CURALEAF AUSTRALIA

Privacy Policy

LEVEL 5, 126 PHILLIP STREET, SYDNEY, 2000, NSW

curaleaf.aus@curaleafint.com

For healthcare professionals only. Curaleaf Australia products are prescription-only and intended for healthcare professionals and stakeholders only. This website does not promote the use or supply of medicinal cannabis to the public. Not for public promotion or recreational use.

Back to top